Department Of Otorhinolaryngology 1

1. Dragonfly Flap: Ethmoidal- and Sphenopalatine-Based Technique for Repair of Large Septal Perforation
2. The triglyceride-glucose index as a biomarker of diabetic retinopathy: a systematic review and meta-analysis
3. Possibilities of automated diagnostics of odontogenic sinusitis according to the computer tomography data
4. Research active posterior rhinomanometry tomography method for nasal breathing determining violations
5. Comparative assessment of antibacterial drugs used at the hospital level before and during COVID-19, according to the WHO AWaRe classification
6. Tyrosine kinase inhibitor toxicity in the treatment of non-small-cell lung cancer: A bibliometric analysis (2009-2025)
7. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
8. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
9. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
10. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
11. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
12. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
13. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
14. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
15. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
16. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
17. Management of anaphylaxis due to COVID-19 vaccines in the elderly
18. Management of anaphylaxis due to COVID-19 vaccines in the elderly
19. Management of anaphylaxis due to COVID-19 vaccines in the elderly
20. Management of anaphylaxis due to COVID-19 vaccines in the elderly
21. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
22. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
23. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
24. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
25. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
26. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
27. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
28. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
29. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
30. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
31. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
32. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
33. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
34. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
35. Unmet needs in hereditary angioedema: an international survey of physicians
36. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
37. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019
38. Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
39. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
40. Epidemiological Characteristics and Maternal Risk Factors of Microtia and Aural Atresia in Kazakhstan
41. Risk Factors in the Formation of Congenital Malformations of the Ear: Microtia and Atresia of the External Auditory Canal
42. Risk Factors in the Formation of Congenital Malformations of the Ear: Microtia and Atresia of the External Auditory Canal
43. Feasibility of Hearing Monitoring using ASSR during One-Stage Tympanoplasty and Ossicular Chain Reconstruction – preliminary report
44. INFLUENCE OF METFORMIN ON THE DIAMETER AND NUMBER OF DNA BREAKS IN BLOOD LYMPHOCYTES IN OBESITY
45. Cochlear implantation in Aksay University Clinic: A review of 135 cases
46. Association between Helicobacterpylori, reflux and chronic rhinosinusitis: a systematic review
47. Finding a molecular genetic marker for the incidence of recurrent episodes of acute obstructive bronchitis in children
48. Mutational screening of GDAP1 in dysphonia associated with Charcot-Marie-Tooth disease: clinical insights and phenotypic effects
49. Global Burden of Orofacial Clefts and the World Surgical Workforce
50. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050
1 2